Peripheral blood mononuclear cells of breast cancer patients can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells

Detalles Bibliográficos
Autores principales: Payne, Kyle K, Zoon, Christine K, Wan, Wen, Marlar, Khin, Keim, Rebecca C, Kenari, Mehrab Nasiri, Kazim, Latif, Bear, Harry D, Manjili, Masoud H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990957/
http://dx.doi.org/10.1186/2051-1426-1-S1-P170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990957/
http://dx.doi.org/10.1186/2051-1426-1-S1-P170

Ejemplares similares